AzTrials
AzTrials

Lumbar RadiculopathyNCT06990113

Three-dimensional Lumbar Myofascial Release and Motor Control in Lumbar Radiculopathy

A study testing three dimensional lumbar myofascial release and conventional treatment. in people with Lumbar Radiculopathy, run by October 6 University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life. Read more about this study

Who is it for?
Ages 35 to 50 years
Conditions the study is for
Lumbar Radiculopathy
What is being tested?
three dimensional lumbar myofascial release and conventional treatment.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Jun 2025to 15 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Their ages range from 35 to 50 years.
  • Both sex
  • Unilateral lumbar radiculopathy for more than 6 months.
  • Normal body mass index (18.5 - 24.99Kg/m2).

Who cannot join

  • • Any other musculoskeletal disorders of the spine or upper extremity
  • Patients with any other Neurological deficits, psychiatric disease lumbar myelopathy, Cognitive problems, vertebral fractures and previous history of spine or lumbar surgery.
  • Clinical instability, recent trauma
  • Structural abnormalities of the spine, osteoporosis, and spasmodic torticollis.
  • Inflammatory or other specific disorders of spina such as ankylosing spondylitis and rheumatoid arthritis

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Lama Saad El-Din Mahmoud

    Al Jīzah, Select State, 0020

Other trials in Egypt

About this study

Official title: Effect of Three-dimensional Lumbar Myofascial Release With Motor Control Training on Back Perception and Pain in Patients With Lumbar Radiculopathy

to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life.

Read the detailed description

PURPOSE: to investigate The Efficacy of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy Patients with lumbar radiculopathy demonstrate impairments in function and range of motion to deficits in patient's quality of life.

HYPOTHESES: It will be hypothesized that there will be no statically Effect of three dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy RESEARCH QUESTION: Is there an Effect of three-dimensional lumbar myofascial release with motor control training on back perception and pain in lumbar radiculopathy

Being tested
three dimensional lumbar myofascial release, conventional treatment.
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • three dimensional lumbar myofascial releaseOther

    Also called (3D) MFR

    Three-dimensional (3D) MFR is a novel approach toward reducing fascial restrictions. It recognizes that fascia exists not only in a linear plane but also in complex multidirectional networks throughout the body.

  • conventional treatment.Other

    conventional treatment, including selected physical therapy, flexibility exercise for the back, static back and abdomen exercises, and electrotherapy

Study groups in NCT06990113
Study groupRoleWhat they receive
three dimensional groupExperimentalreceived three dimensional lumbar myofascial release with motor control training, and conventional treatment
Receives: Other: three dimensional lumbar myofascial release; Other: conventional treatment.
conventional groupExperimentalreceived conventional physical therapy modalities, including electrotherapy and flexibility treatment
Receives: Other: conventional treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fremantle Back Awareness Questionnaire

    The Fremantle Back Awareness Questionnaire (FreBAQ) has been found to possess adequate psychometric properties in low back pain (LBP) patients worldwide

    Measured: four weeks

  2. Oswestry Low Back Pain Disability Questionnaire

    The Oswestry Disability Index (ODI) a patient-completed questionnaire which gives a subjective percentage score of level of function (disability) in activities of daily living in those rehabilitating from low back pain

    Measured: four weeks

Secondary outcomes (2)
  1. pressure pain algometer

    Algometers are designed to quantify and document levels of tenderness via pressure pain threshold measurement and pain sensitivity via pressure pain tolerance measurement.

    Measured: four weeks

  2. visual analog scale

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions

    Measured: four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2025
  2. Study start1 Jun 2025
  3. Primary completion15 Jun 2026
  4. Study completion15 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The patients were randomly divided into two equal groups; Study group (16 patients): received three dimensional lumbar myofascial release with motor control training, and conventional treatment. Control group (16 patients): received conventional treatment.
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06990113
Sponsor's protocol ID
P.T.REC/012/005789
Status last verified
Aug 2026
First submitted
18 May 2025
Last updated
25 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing three dimensional lumbar myofascial release and conventional treatment. in people with Lumbar Radiculopathy, run by October 6 University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fremantle Back Awareness Questionnaire (time frame: four weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in